Cargando…
Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model
Triple negative breast cancer (TNBC) is known for being very aggressive, heterogeneous and highly metastatic. The standard of care treatment is still chemotherapy, with adjacent toxicity and low efficacy, highlighting the need for alternative and more effective therapeutic strategies. Edelfosine, an...
Autores principales: | Saraiva, Sofia M., Gutiérrez-Lovera, Carlha, Martínez-Val, Jeannette, Lores, Sainza, Bouzo, Belén L., Díez-Villares, Sandra, Alijas, Sandra, Pensado-López, Alba, Vázquez-Ríos, Abi Judit, Sánchez, Laura, de la Fuente, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110995/ https://www.ncbi.nlm.nih.gov/pubmed/33972572 http://dx.doi.org/10.1038/s41598-021-87968-4 |
Ejemplares similares
-
Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer
por: Bouzo, Belén L., et al.
Publicado: (2021) -
Zebrafish as a platform to evaluate the potential of lipidic nanoemulsions for gene therapy in cancer
por: Cascallar, María, et al.
Publicado: (2022) -
Biodistribution of (68/67)Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging
por: Díez-Villares, Sandra, et al.
Publicado: (2021) -
What Zebrafish and Nanotechnology Can Offer for Cancer Treatments in the Age of Personalized Medicine
por: Cascallar, María, et al.
Publicado: (2022) -
Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics
por: Nagachinta, Surasa, et al.
Publicado: (2020)